JERUSALEM and SINGAPORE, September 27, 2017 /PRNewswire/ --
Funds will Contribute to Expansion and Development of Integra's Portfolio, Bringing Hebrew University's Life Science Innovations to Market
(Logo: http://mma.prnewswire.com/media/561848/Integra_Holdings_Logo.jpg )
Integra Holdings, an investment company exclusively focused on life science innovations originating from the Hebrew University, today announced the first closing of a $25 million investment. Temasek, which led the round with an investment of $15M, was joined by Arie Capital, with an initial investment of $2M. The Israeli Teachers' and Kindergarten's Study Funds, one of Integra's current shareholders, also participated in this financing round. The funds raised will be used to advance Integra Holdings' existing portfolio companies and to create new companies, based on promising technologies originating from the Hebrew University of Jerusalem.
"I am proud to welcome Temasek and Arie Capital to our circle of investors" said Dr. Liana Patt, CEO Integra Holdings [http://www.integra-holdings.com ]. "This strategic investment reinforces the global recognition of the Hebrew University's exceptional contribution to life science innovations and Integra's robust and growing portfolio".
Temasek is an investment company, headquartered in Singapore, with a net portfolio value of US$197 billion (as of 31 March 2017). Temasek operates through 10 international offices and a staff of over 630 people globally.
"This latest round of investment will allow more breakthrough discoveries to realize their potential and reach a broader community of entrepreneurs, investors and industry partners" said Mr. Lior Buchman, CFO Integra Holdings.
About Integra Holdings [http://www.integra-holdings.com ] Founded in 2012 by Yissum, the Technology Transfer Company of the Hebrew University, Integra Holdings' mission is to bring the Hebrew University's Life Science Academic Excellence to market.
Integra Holdings is a unique venture organization with a balanced portfolio of investments, based on an exclusive selection of life science companies, and focused on proprietary, first-in class innovations in the fields of biotechnology, pharmaceuticals, diagnostics and medical devices.
Integra Holdings takes a hands-on approach by providing its portfolio companies with the strategic planning, business development and research and development guidance they need to bring their technologies to market. For more information, please visit http://www.integra-holdings.com.
About Temasek [http://www.temasek.com.sg ] Incorporated in 1974, Temasek is an investment company headquartered in Singapore. Supported by 10 offices internationally Temasek owns a S$275 billion (US$197 billion) portfolio, mainly in Singapore and the rest of Asia.
Temasek's portfolio covers a broad spectrum of industries: financial services; telecommunications; media & technology; transportation & industrials; consumer & real estate; life sciences & agribusiness as well as energy & resources. At Temasek we believe collective action is needed to achieve the United Nations Sustainable Development Goals by 2030 to uplift the global community and deliver a sustainable world. We will do our part as a responsible investor, institution and steward, for our present and future generations. For more information, please visit http://www.temasek.com.sg
About Arie Capital Arie Capital was founded in London in 2015, with the purpose of establishing a triangular link between the UK, Israel and China, and has already raised $45M and invested in more than 10 companies.
Mr. Lior Buchman
Chief Finance Officer